Hip Reconstruction Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Hip Reconstruction Pipeline Market Report Overview

Hip reconstruction or hip replacement is a procedure that involves the replacement of the damaged or diseased parts of the hip joint. This category includes devices (implants) used in hip replacement procedures.

The hip reconstruction pipeline market research report provides comprehensive information about the hip reconstruction pipeline reconstruction with a comparative analysis of the reconstruction at various stages of development and information about the clinical trials which are in progress.

Key Segments ·       Primary Hip Replacement

·       Revision Hip Replacement

·       Hip Resurfacing

·       Partial Hip Replacement

·       Primary Cemented Hip Replacement

·       Primary Cementless Hip Replacement

Key Territories ·       The US

·       Japan

·       Europe

·       China

·       India

·       Australia

·       Canada

Key Regulatory Paths ·       510(k)

·       CE

·       NMPA

·       Ninsho

·       TGA

·       PMA

·       MDL

·       ICAC

Leading Companies ·       4WEB Medical Inc

·       Arigin Medical Co Ltd

·       Beijing Ansong Technology Co Ltd

·       BioPoly RS LLC

·       Bonovo Orthopedics Inc

·       Corin Group Ltd

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Hip Reconstruction Pipeline Market Segments

Some of the key segments in the hip reconstruction pipeline market are primary hip replacement, revision hip replacement, hip resurfacing, partial hip replacement, primary cemented hip replacement, and primary cementless hip replacement. As of May 2023, primary hip replacement has the highest share.

Hip Reconstruction Pipeline Market Analysis, by Segments, 2023 (%)

Hip Reconstruction Pipeline Market Analysis, by Segments, 2023 (%)

For more segment insights into the hip reconstruction pipeline market, download a free report sample

Hip Reconstruction Pipeline Market Segmentation by Territories

Some of the key territories having hip reconstruction products in the pipeline are the US, Japan, Europe, China, India, Australia, and Canada. As of May 2023, the US had the highest number of products in the pipeline compared to the others in North America as well as the global hip reconstruction products market.

Hip Reconstruction Pipeline Market Analysis, by Territories, 2023 (%)

Hip Reconstruction Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into hip reconstruction pipeline market, download a free report sample

Hip Reconstruction Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths followed by the hip reconstruction pipeline products are 510(k), CE, NMPA, Ninsho, TGA, PMA, MDL, and ICAC among others.  As of May 2023, most of the reconstruction follows the 510(k) pathway to enter the market.

Hip Reconstruction Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

Hip Reconstruction Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the hip reconstruction pipeline market, download a free report sample

Hip Reconstruction Pipeline Market – Competitive Landscape

Some of the leading companies in the hip reconstruction pipeline reconstruction market are 4WEB Medical Inc, Arigin Medical Co Ltd, Beijing Ansong Technology Co Ltd, BioPoly RS LLC, Bonovo Orthopedics Inc and Corin Group Ltd among others.

4WEB Medical Inc: 4WEB Medical Inc (4WEB) is an implant device company. The company designs 3D-printed titanium implants. It utilizes 3D printing technology to develop 4WEB Medical’s proprietary truss implant platform. 4WEB is headquartered in Frisco, Texas, the US.

Segments Covered in the Report

Hip Reconstruction Pipeline Market Segments Outlook

  • Primary Hip Replacement
  • Revision Hip Replacement
  • Hip Resurfacing
  • Partial Hip Replacement
  • Primary Cemented Hip Replacement
  • Primary Cementless Hip Replacement

Hip Reconstruction Pipeline Market Territories Outlook

  • The US
  • Japan
  • Europe
  • China
  • India
  • Australia
  • Canada

Hip Reconstruction Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • NMPA
  • Ninsho
  • TGA
  • PMA
  • MDL
  • ICAC

Scope

  • Extensive coverage of the hip reconstruction under development
  • Reviews details of major pipeline reconstruction which include, product description, licensing and collaboration details, and other developmental activities
  • Reviews the major players involved in the development of hip reconstruction and list all their pipeline projects
  • The coverage of pipeline reconstruction based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline reconstruction
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of hip reconstruction under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

4WEB Medical Inc
Arigin Medical Co Ltd
Bactiguard Holding AB
Beijing Ansong Technology Co Ltd
BioPoly LLC
Biotechni SAS
Bonovo Orthopedics Inc
Corin Group Ltd
CytexOrtho
DePuy Synthes Inc
Dynamic Implant Inc
Embody Orthopaedic Ltd
Exactech Inc
Flexable Orthopedics
Fortis Orthopedics
Fraunhofer Institute for Applied Polymer Research
Fuse Medical Inc
Gyder Surgical Pty Ltd
Hangzhou Lancet Robotics Co Ltd
Hip Innovation Technology LLC
Inertial Orthopaedic Navigation Solutions (IONS) Pty Ltd
Inor Medical Products Ltd
JointMedica Ltd
JRI Orthopaedics Ltd
Kyocera Corp
Lifespans Ltd
Limacorporate SpA
MicroPort Orthopedics Inc
MicroPort Scientific Corp
MX Orthopedics Corp
Nano Interface Technology LLC (Inactive)
OrthoGrid Systems
PreSRV Ltd.
Pro-Dex Inc
Renova Orthopedics LLC (Inactive)
Rochester Institute of Technology
SINTEF
SINTX Technologies Inc
Smith & Nephew Plc
Stanford University
University of Auckland
University of Maine
University of Oxford
University of South Florida
University of Southampton
University of Warwick
Xtremity & Spinal Solutions Ltd
Zimmer Biomet Holdings Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 12

2 Introduction 13

2.1 Hip Reconstruction Overview 13

3 Products under Development 14

3.1 Hip Reconstruction – Pipeline Products by Stage of Development 14

3.2 Hip Reconstruction – Pipeline Products by Segment 15

3.3 Hip Reconstruction – Pipeline Products by Territory 16

3.4 Hip Reconstruction – Pipeline Products by Regulatory Path 17

3.5 Hip Reconstruction – Pipeline Products by Estimated Approval Date 18

3.6 Hip Reconstruction – Ongoing Clinical Trials 19

4 Hip Reconstruction – Pipeline Products under Development by Companies 20

4.1 Hip Reconstruction Companies – Pipeline Products by Stage of Development 20

4.2 Hip Reconstruction – Pipeline Products by Stage of Development 22

5 Hip Reconstruction Companies and Product Overview 25

5.1 4WEB Medical Inc Company Overview 25

5.1.1 4WEB Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.2 Arigin Medical Co Ltd Company Overview 26

5.2.1 Arigin Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 26

5.3 Bactiguard Holding AB Company Overview 27

5.3.1 Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview 27

5.4 Beijing Ansong Technology Co Ltd Company Overview 28

5.4.1 Beijing Ansong Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

5.5 BioPoly LLC Company Overview 29

5.5.1 BioPoly LLC Pipeline Products & Ongoing Clinical Trials Overview 29

5.6 Biotechni SAS Company Overview 30

5.6.1 Biotechni SAS Pipeline Products & Ongoing Clinical Trials Overview 30

5.7 Bonovo Orthopedics Inc Company Overview 32

5.7.1 Bonovo Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.8 Corin Group Ltd Company Overview 34

5.8.1 Corin Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

5.9 CytexOrtho Company Overview 36

5.9.1 CytexOrtho Pipeline Products & Ongoing Clinical Trials Overview 36

5.10 DePuy Synthes Inc Company Overview 38

5.10.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.11 Dynamic Implant Inc Company Overview 41

5.11.1 Dynamic Implant Inc Pipeline Products & Ongoing Clinical Trials Overview 41

5.12 Embody Orthopaedic Ltd Company Overview 42

5.12.1 Embody Orthopaedic Ltd Pipeline Products & Ongoing Clinical Trials Overview 42

5.13 Exactech Inc Company Overview 43

5.13.1 Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.14 Flexable Orthopedics Company Overview 45

5.14.1 Flexable Orthopedics Pipeline Products & Ongoing Clinical Trials Overview 45

5.15 Fortis Orthopedics Company Overview 46

5.15.1 Fortis Orthopedics Pipeline Products & Ongoing Clinical Trials Overview 46

5.16 Fraunhofer Institute for Applied Polymer Research Company Overview 47

5.16.1 Fraunhofer Institute for Applied Polymer Research Pipeline Products & Ongoing Clinical Trials Overview 47

5.17 Fuse Medical Inc Company Overview 48

5.17.1 Fuse Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 48

5.18 Gyder Surgical Pty Ltd Company Overview 49

5.18.1 Gyder Surgical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

5.19 Hangzhou Lancet Robotics Co Ltd Company Overview 50

5.19.1 Hangzhou Lancet Robotics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

5.20 Hip Innovation Technology LLC Company Overview 51

5.20.1 Hip Innovation Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 51

5.21 Inertial Orthopaedic Navigation Solutions (IONS) Pty Ltd Company Overview 54

5.21.1 Inertial Orthopaedic Navigation Solutions (IONS) Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 54

5.22 Inor Medical Products Ltd Company Overview 55

5.22.1 Inor Medical Products Ltd Pipeline Products & Ongoing Clinical Trials Overview 55

5.23 JointMedica Ltd Company Overview 57

5.23.1 JointMedica Ltd Pipeline Products & Ongoing Clinical Trials Overview 57

5.24 JRI Orthopaedics Ltd Company Overview 58

5.24.1 JRI Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

5.25 Kyocera Corp Company Overview 74

5.25.1 Kyocera Corp Pipeline Products & Ongoing Clinical Trials Overview 74

5.26 Lifespans Ltd Company Overview 75

5.26.1 Lifespans Ltd Pipeline Products & Ongoing Clinical Trials Overview 75

5.27 Limacorporate SpA Company Overview 76

5.27.1 Limacorporate SpA Pipeline Products & Ongoing Clinical Trials Overview 76

5.28 MicroPort Orthopedics Inc Company Overview 79

5.28.1 MicroPort Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview 79

5.29 MicroPort Scientific Corp Company Overview 84

5.29.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 84

5.30 MX Orthopedics Corp Company Overview 88

5.30.1 MX Orthopedics Corp Pipeline Products & Ongoing Clinical Trials Overview 88

5.31 Nano Interface Technology LLC (Inactive) Company Overview 89

5.31.1 Nano Interface Technology LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 89

5.32 OrthoGrid Systems Company Overview 90

5.32.1 OrthoGrid Systems Pipeline Products & Ongoing Clinical Trials Overview 90

5.33 PreSRV Ltd. Company Overview 91

5.33.1 PreSRV Ltd. Pipeline Products & Ongoing Clinical Trials Overview 91

5.34 Pro-Dex Inc Company Overview 92

5.34.1 Pro-Dex Inc Pipeline Products & Ongoing Clinical Trials Overview 92

5.35 Renova Orthopedics LLC (Inactive) Company Overview 93

5.35.1 Renova Orthopedics LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 93

5.36 Rochester Institute of Technology Company Overview 94

5.36.1 Rochester Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 94

5.37 SINTEF Company Overview 95

5.37.1 SINTEF Pipeline Products & Ongoing Clinical Trials Overview 95

5.38 SINTX Technologies Inc Company Overview 96

5.38.1 SINTX Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 96

5.39 Smith & Nephew Plc Company Overview 98

5.39.1 Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview 98

5.40 Stanford University Company Overview 101

5.40.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 101

5.41 University of Auckland Company Overview 102

5.41.1 University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 102

5.42 University of Maine Company Overview 103

5.42.1 University of Maine Pipeline Products & Ongoing Clinical Trials Overview 103

5.43 University of Oxford Company Overview 104

5.43.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 104

5.44 University of South Florida Company Overview 105

5.44.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 105

5.45 University of Southampton Company Overview 107

5.45.1 University of Southampton Pipeline Products & Ongoing Clinical Trials Overview 107

5.46 University of Warwick Company Overview 108

5.46.1 University of Warwick Pipeline Products & Ongoing Clinical Trials Overview 108

5.47 Xtremity & Spinal Solutions Ltd Company Overview 110

5.47.1 Xtremity & Spinal Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 110

5.48 Zimmer Biomet Holdings Inc Company Overview 111

5.48.1 Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 111

6 Hip Reconstruction- Recent Developments 114

6.1 May 16, 2023: Exactech accelerates international expansion of its Newton balanced Knee technology 114

6.2 May 15, 2023: Materialise to hold annual shareholders’ meeting on June 6, 2023 114

6.3 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 114

6.4 Apr 27, 2023: Materialise announces new chief financial officer 115

6.5 Apr 26, 2023: Orthofix Medical schedules Q1 earnings release and conference call for May 9, 2023 115

6.6 Apr 26, 2023: Smith & Nephew announces Q1 2023 trading update 115

6.7 Apr 12, 2023: Medtronic has a layoff in California 118

6.8 Apr 10, 2023: Henry Ford Health Appoints New Orthopedics Chair and Medical Director 118

6.9 Apr 06, 2023: Smith & Nephew Notice of First Quarter 2023 Trading Report 119

6.10 Mar 28, 2023: Stryker announces Annual Meeting of Shareholders 119

6.11 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 119

6.12 Mar 08, 2023: Study: Higher Fracture Risk After Total Hip Replacement When Cementless Implant Used to Treat Femoral Neck Fracture 120

6.13 Mar 07, 2023: Advancements in digital technology enable more personalized patient care 121

6.14 Mar 06, 2023: Smith & Nephew Announces Annual Financial Report 2022 122

6.15 Mar 06, 2023: Smith & Nephew Notice of 2023 Annual General Meeting 123

6.16 Feb 21, 2023: THINK Surgical Announces Chief Technology Officer 123

6.17 Feb 21, 2023: Smith & Nephew Announces Fourth Quarter and Full Year 2022 Results 123

6.18 Feb 21, 2023: Orthofix Medical Schedules Fourth Quarter Earnings Release and Conference Call for March 6, 2023 125

6.19 Feb 15, 2023: World Leader In Musculoskeletal Health HSS Announces Douglas E. Padgett, MD to become Next Surgeon-in-Chief and Medical Director 125

6.20 Feb 06, 2023: Hospital for Special Surgery Announces Rightmove Appoints Marcus Osborne As Ceo 126

6.21 Feb 03, 2023: Medacta Group reports a robust

20.4% revenue growth in 2022 reaching

437.1 M€ 127

6.22 Jan 31, 2023: Materialise to Report Fourth Quarter 2022 Earnings on Tuesday, February 14, 2023 128

6.23 Jan 27, 2023: Hospital for Special Surgery Announces Leadership Change 128

6.24 Jan 24, 2023: IMPLANET Reports 2022 Annual Revenue of €8.0 Million, up 31% 129

6.25 Jan 13, 2023: HSS Florida Continues to Grow With Appointment of Tara M. McCoy As CEO 131

6.26 Jan 10, 2023: Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022 131

6.27 Jan 10, 2023: Hydrogel injections treat antibiotic-resistant infections after hip, knee replacements 132

6.28 Jan 09, 2023: Orthofix Medical Announces Preliminary SeaSpine and Orthofix 2022 Fourth Quarter and Full-Year Net Sales Results 132

6.29 Jan 04, 2023: Andreas Weller Named Tecomet President & Chief Executive Officer 135

6.30 Nov 23, 2022: Medtronic Reports Quarterly Earnings 135

6.31 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 135

6.32 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 141

6.33 Nov 14, 2022: THINK Surgical Announces Experienced Commercial Leadership Team 141

6.34 Nov 10, 2022: Paragon 28 Reports Third Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance 142

6.35 Nov 02, 2022: MicroPort Orthopedics releases the HIPTURN tensioning instrument: An exclusive in-situ trialing device 143

6.36 Oct 27, 2022: Materialise Reports Third Quarter 2022 Results 143

6.37 Oct 27, 2022: Paragon 28 to Report Third Quarter 2022 Financial Results on November 10, 2022 145

6.38 Oct 26, 2022: Beijing Chunlizhengda Medical Instruments Co Ltd announced 2022 third quarter report 145

6.39 Oct 25, 2022: Orthofix Medical Schedules Third Quarter Earnings Release and Conference Call for November 3, 2022 145

6.40 Oct 17, 2022: Corin Announces Chief Financial Officer Transition 146

6.41 Oct 11, 2022: Orthofix Announces Preliminary Third Quarter and Year-To-Date 2022 Net Sales Results 146

6.42 Oct 04, 2022: Exactech Names New Chief Financial Officer 148

6.43 Sep 23, 2022: Beijing Chunlizhengda Medical Instruments Co Ltd announced interim report for 2022 148

6.44 Sep 22, 2022: Harvinder S. Sandhu, MD, Appointed Chair of the Department of Orthopedics at Stamford Hospital 148

6.45 Sep 20, 2022: Implanet Publishes its 2022 Half-year Results 149

6.46 Sep 14, 2022: Orthofix Medical Announces Participation in Upcoming Sidoti Virtual Investor Conference 151

6.47 Sep 08, 2022: Robert G. Riney Named Henry Ford Health President and CEO 152

6.48 Sep 07, 2022: Medtronic to appear at September investor conferences 152

6.49 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results 152

6.50 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results 155

6.51 Aug 12, 2022: Sintx Technologies Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 158

6.52 Aug 03, 2022: Paragon 28 Reports Second Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance 159

6.53 Aug 02, 2022: Zimmer Biomet Announces Second Quarter 2022 Financial Results 160

6.54 Jul 29, 2022: Medacta Group reports

19.0% growth of half-year revenue 160

6.55 Jul 28, 2022: Smith+Nephew Second Quarter and First Half 2022 Results 161

6.56 Jul 28, 2022: Materialise Reports Second Quarter 2022 Results 162

6.57 Jul 18, 2022: Paragon 28 to Present at The Canaccord Genuity 42nd Annual Growth Conference 163

6.58 Jul 18, 2022: Paragon 28 To Report Second Quarter 2022 Financial Results on August 3, 2022 164

6.59 Jul 12, 2022: Aspire & USF Pass $10M in ticket & donation revenue 164

6.60 Jul 11, 2022: Implanet Reports Its Revenue for Q2 2022, Up 33% 164

6.61 Jun 30, 2022: Advanced total joint care emphasizing on total knee and hip replacement – less pain, fast recovery with ability to walk within 24 hours 166

6.62 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director 167

6.63 Jun 10, 2022: Minutes of Implanet’s Annual General Meeting Held on June 9, 2022 167

7 Appendix 169

7.1 Methodology 169

7.2 About GlobalData 172

7.3 Contact Us 172

7.4 Disclaimer 172

Table

Hip Reconstruction – Pipeline Products by Stage of Development 14

Hip Reconstruction – Pipeline Products by Segment 15

Hip Reconstruction – Pipeline Products by Territory 16

Hip Reconstruction – Pipeline Products by Regulatory Path 17

Hip Reconstruction – Pipeline Products by Estimated Approval Date 18

Hip Reconstruction – Ongoing Clinical Trials 19

Hip Reconstruction Companies – Pipeline Products by Stage of Development 20

Hip Reconstruction – Pipeline Products by Stage of Development 22

4WEB Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Truss Implant – Hip Procedures – Product Status 25

Truss Implant – Hip Procedures – Product Description 25

Arigin Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 26

Acetabular Cup – Product Status 26

Acetabular Cup – Product Description 26

Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview 27

Bactiguard Hip Joint Reconstruction Implant – Product Status 27

Bactiguard Hip Joint Reconstruction Implant – Product Description 27

Beijing Ansong Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

Ceramic Hip Implant – Product Status 28

Ceramic Hip Implant – Product Description 28

BioPoly LLC Pipeline Products & Ongoing Clinical Trials Overview 29

Biopoly RS Partial Resurfacing System – Hip – Product Status 29

Biopoly RS Partial Resurfacing System – Hip – Product Description 29

Biotechni SAS Pipeline Products & Ongoing Clinical Trials Overview 30

MULTI-T64 – Product Status 30

MULTI-T64 – Product Description 30

MULTI-T66 – Product Status 31

MULTI-T66 – Product Description 31

Bonovo Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview 32

JMM Total Hip System – Product Status 32

JMM Total Hip System – Product Description 32

Konknow Hip System – Product Status 33

Konknow Hip System – Product Description 33

Corin Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

OPSReView – Product Status 34

OPSReView – Product Description 34

Trinity Plus – Product Status 35

Trinity Plus – Product Description 35

CytexOrtho Pipeline Products & Ongoing Clinical Trials Overview 36

Bio-Artificial Cartilage Implant – Femoroacetabular Impingement – Product Status 36

Bio-Artificial Cartilage Implant – Femoroacetabular Impingement – Product Description 36

Bio-Artificial Cartilage Implant – Hip Resurfacing – Product Status 37

Bio-Artificial Cartilage Implant – Hip Resurfacing – Product Description 37

DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 38

Bone Preserving Hip Stem – Product Status 38

Bone Preserving Hip Stem – Product Description 38

New Poly Hip Bearing – Product Status 39

New Poly Hip Bearing – Product Description 39

Next Generation Hip System – Product Status 39

Next Generation Hip System – Product Description 39

PE ALTRX Polyethylene Liner – Product Status 40

PE ALTRX Polyethylene Liner – Product Description 40

Dynamic Implant Inc Pipeline Products & Ongoing Clinical Trials Overview 41

Dynamic Implant – Hip Arthritis – Product Status 41

Dynamic Implant – Hip Arthritis – Product Description 41

Embody Orthopaedic Ltd Pipeline Products & Ongoing Clinical Trials Overview 42

H1 Hip Resurfacing Implant – Product Status 42

H1 Hip Resurfacing Implant – Product Description 42

Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Alteon Revision Modular System – Product Status 43

Alteon Revision Modular System – Product Description 43

Hip Revision System – Product Status 44

Hip Revision System – Product Description 44

Flexable Orthopedics Pipeline Products & Ongoing Clinical Trials Overview 45

Flex-Able – Product Status 45

Flex-Able – Product Description 45

Fortis Orthopedics Pipeline Products & Ongoing Clinical Trials Overview 46

MiHip System – Product Status 46

MiHip System – Product Description 46

Fraunhofer Institute for Applied Polymer Research Pipeline Products & Ongoing Clinical Trials Overview 47

Enhanced Durability Resurfacing Endoprosthesis – Product Status 47

Enhanced Durability Resurfacing Endoprosthesis – Product Description 47

Fuse Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 48

Sterizo Total Hip System – Product Status 48

Sterizo Total Hip System – Product Description 48

Gyder Surgical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

Gyder Hip Navigation System – Product Status 49

Gyder Hip Navigation System – Product Description 49

Hangzhou Lancet Robotics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

RobPath Total Hip Application – Product Status 50

RobPath Total Hip Application – Product Description 50

Hip Innovation Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 51

HIT Hip Replacement System – Product Status 51

HIT Hip Replacement System – Product Description 51

Hip Innovation Technology LLC – Ongoing Clinical Trials Overview 52

HIT Hip Replacement System – A Multi-center Prospective Study of the Hip Innovation Technology (HIT) Hip Replacement System in Primary Total Hip Arthroplasty 53

HIT Hip Replacement System – Safety and Effectiveness of the Hip Innovation Technology Reverse Hip Replacement System in Primary Total Hip Arthroplasty: A Pivotal Study 53

Inertial Orthopaedic Navigation Solutions (IONS) Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 54

MACNAV Computer-Assisted Hip Replacement Navigation System – Product Status 54

MACNAV Computer-Assisted Hip Replacement Navigation System – Product Description 54

Inor Medical Products Ltd Pipeline Products & Ongoing Clinical Trials Overview 55

INOR TOTAL HIP SYSTEM Chromium Cobalt XL Series-LONG NECK – Product Status 55

INOR TOTAL HIP SYSTEM Chromium Cobalt XL Series-LONG NECK – Product Description 55

Inor Total Hip System Stainless Steel XL Series – Long Neck – Product Status 56

Inor Total Hip System Stainless Steel XL Series – Long Neck – Product Description 56

JointMedica Ltd Pipeline Products & Ongoing Clinical Trials Overview 57

The Polymotion Hip Resurfacing System – Product Status 57

The Polymotion Hip Resurfacing System – Product Description 57

JRI Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

Acetabular Cup Liner – Product Status 58

Acetabular Cup Liner – Product Description 59

Avanteon Hip System – Product Status 59

Avanteon Hip System – Product Description 60

Ceramic Femoral Head – Product Status 60

Ceramic Femoral Head – Product Description 61

Furlong Evolution – Product Status 61

Furlong Evolution – Product Description 61

Furlong H-A.C And CSF Plus Coated Acetabular Cup – Product Status 62

Furlong H-A.C And CSF Plus Coated Acetabular Cup – Product Description 62

Furlong H-A.C Coated Uncemented Hip System – Product Status 62

Furlong H-A.C Coated Uncemented Hip System – Product Description 63

Furlong H-A.C. Acetabular Cup – Product Status 63

Furlong H-A.C. Acetabular Cup – Product Description 63

Furlong H-A.C. Hemi-Arthroplasty System – Product Status 64

Furlong H-A.C. Hemi-Arthroplasty System – Product Description 64

Furlong H-A.C. Revision Hip Stem – Product Status 64

Furlong H-A.C. Revision Hip Stem – Product Description 65

Furlong H-A.C. THR System – Product Status 65

Furlong H-A.C. THR System – Product Description 66

Furlong Hemi-Arthroplasty System – Product Status 66

Furlong Hemi-Arthroplasty System – Product Description 67

Furlong Modular THR – Product Status 67

Furlong Modular THR – Product Description 68

Furlong Securus Femoral Revision System – Product Status 68

Furlong Securus Femoral Revision System – Product Description 69

MRP-Titan – Product Status 69

MRP-Titan – Product Description 69

MRS Comfort Revision Cup – Product Status 70

MRS Comfort Revision Cup – Product Description 70

JRI Orthopaedics Ltd – Ongoing Clinical Trials Overview 71

Furlong Evolution – Evaluation of the Furlong Evolution Uncemented Hip Prosthesis with Special Emphasize on the Use of Collared Design or Not. A Prospective, Randomized Study Evaluated by RadioStereometric Analysis (RSA) and DXA 72

Avanteon Hip System – Prospective, Open Label, Single Arm, Monocentric Clinical Study Intended to Observe Efficacy and Safety of the Aeon-shaft (Artificial Hip Joint), Fa. Brehm, in Patients with Osteoarthritis of the Hip or a Fracture of the Femoral Neck 73

Kyocera Corp Pipeline Products & Ongoing Clinical Trials Overview 74

Aquala Liner – Product Status 74

Aquala Liner – Product Description 74

Lifespans Ltd Pipeline Products & Ongoing Clinical Trials Overview 75

Lifespans Soft Hip Implant – Product Status 75

Lifespans Soft Hip Implant – Product Description 75

Limacorporate SpA Pipeline Products & Ongoing Clinical Trials Overview 76

Mueller Cemented Cups – Product Status 76

Mueller Cemented Cups – Product Description 76

Limacorporate SpA – Ongoing Clinical Trials Overview 77

Mueller Cemented Cups – A Prospective Clinical Study Evaluating Clinical, Radiographic and Patient-reported Outcomes of THA with Cemented Acetabular Cups 78

MicroPort Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview 79

Classic Revision Stem – Product Status 79

Classic Revision Stem – Product Description 79

Hip Alignment Guide – Product Status 80

Hip Alignment Guide – Product Description 80

Prime Constrained Liner – Product Status 80

Prime Constrained Liner – Product Description 80

Procotyl P Acetabular Cup System – Product Status 81

Procotyl P Acetabular Cup System – Product Description 81

Profemur Cemented XM Femoral Stem – Product Status 81

Profemur Cemented XM Femoral Stem – Product Description 82

Zenith 3D Acetabular System – Product Status 82

Zenith 3D Acetabular System – Product Description 82

Zenith Acetabular System – Product Status 83

Zenith Acetabular System – Product Description 83

Zirconium-Niobium Alloy Femoral Head – Product Status 83

Zirconium-Niobium Alloy Femoral Head – Product Description 83

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 84

Next Generation Optimized ML Taper Hip Stem – Product Status 84

Next Generation Optimized ML Taper Hip Stem – Product Description 84

VenusOne 3D-Printed Acetabular System – Product Status 85

VenusOne 3D-Printed Acetabular System – Product Description 85

VenusOne Acetabular System With Plasma Spray – Product Status 85

VenusOne Acetabular System With Plasma Spray – Product Description 85

VenusOne Bio-Acetabular System – Product Status 86

VenusOne Bio-Acetabular System – Product Description 86

VenusOne Sintered-Ti Acetabular System – Product Status 86

VenusOne Sintered-Ti Acetabular System – Product Description 86

XL & E-POLY BIOFOAM – Product Status 87

XL & E-POLY BIOFOAM – Product Description 87

MX Orthopedics Corp Pipeline Products & Ongoing Clinical Trials Overview 88

Shape Memory Alloy Hip Implant – Product Status 88

Shape Memory Alloy Hip Implant – Product Description 88

Nano Interface Technology LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 89

Hip Implant – Product Status 89

Hip Implant – Product Description 89

OrthoGrid Systems Pipeline Products & Ongoing Clinical Trials Overview 90

HipFXGrid – Product Status 90

HipFXGrid – Product Description 90

PreSRV Ltd. Pipeline Products & Ongoing Clinical Trials Overview 91

Atlas Femoral Head Preserving Prosthesis – Product Status 91

Atlas Femoral Head Preserving Prosthesis – Product Description 91

Pro-Dex Inc Pipeline Products & Ongoing Clinical Trials Overview 92

Acetabular Cup Revision Tool – Product Status 92

Acetabular Cup Revision Tool – Product Description 92

Renova Orthopedics LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 93

A-FX Hip Fracture System – Product Status 93

A-FX Hip Fracture System – Product Description 93

Rochester Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 94

Artificial Hip Joint – Product Status 94

Artificial Hip Joint – Product Description 94

SINTEF Pipeline Products & Ongoing Clinical Trials Overview 95

Smart Hip Prosthesis – Product Status 95

Smart Hip Prosthesis – Product Description 95

SINTX Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 96

Infinia Total Hip Implant II – Product Status 96

Infinia Total Hip Implant II – Product Description 96

Total Hip Implant – Product Status 97

Total Hip Implant – Product Description 97

Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview 98

Navio Total Hip Arthroplasty System – Product Status 98

Navio Total Hip Arthroplasty System – Product Description 98

RI.HIP NAVIGATION – Product Status 99

RI.HIP NAVIGATION – Product Description 99

Total Hip Arthroplasty Instrument – Product Status 99

Total Hip Arthroplasty Instrument – Product Description 100

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 101

Avascular Necrosis Implant – Product Status 101

Avascular Necrosis Implant – Product Description 101

University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 102

Acetabular Reconstruction Implant – Product Status 102

Acetabular Reconstruction Implant – Product Description 102

University of Maine Pipeline Products & Ongoing Clinical Trials Overview 103

Stemless Hip Replacement Prosthesis – Product Status 103

Stemless Hip Replacement Prosthesis – Product Description 103

University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 104

Surgical Device – Hip Replacement – Product Status 104

Surgical Device – Hip Replacement – Product Description 104

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 105

Cannulated Screw Jig – Product Status 105

Cannulated Screw Jig – Product Description 105

Injectable Hip Hemiarthroplasty Device – Product Status 106

Injectable Hip Hemiarthroplasty Device – Product Description 106

University of Southampton Pipeline Products & Ongoing Clinical Trials Overview 107

EnDuRE – Product Status 107

EnDuRE – Product Description 107

University of Warwick Pipeline Products & Ongoing Clinical Trials Overview 108

Femoral Head Positioning Device – Product Status 108

Femoral Head Positioning Device – Product Description 108

Hip Prostheses – Product Status 109

Hip Prostheses – Product Description 109

Xtremity & Spinal Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 110

Phoenix Re-Surf – Product Status 110

Phoenix Re-Surf – Product Description 110

Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 111

E1 Avantage Hip Cup – Product Status 111

E1 Avantage Hip Cup – Product Description 111

Zimmer Biomet Holdings Inc – Ongoing Clinical Trials Overview 112

E1 Avantage Hip Cup – RCT of the Sirius Stem Used in Conjunction with the Exceed ABT Cemented Cup and OptiPac/OptiVac Cement – Model Based RSA, Clinical and Radiographic Outcomes 113

Glossary 171

Figures

Hip Reconstruction – Pipeline Products by Stage of Development 14

Hip Reconstruction – Pipeline Products by Segment 15

Hip Reconstruction – Pipeline Products by Territory 16

Hip Reconstruction – Pipeline Products by Regulatory Path 17

Hip Reconstruction – Pipeline Products by Estimated Approval Date 18

Hip Reconstruction – Ongoing Clinical Trials 19

Frequently asked questions

Hip Reconstruction Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Hip Reconstruction Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Hip Reconstruction Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Hip Reconstruction Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.